Improving Access to Quality Medicines in South Sudan
Improving Access to Quality Medicines in South Sudan
Improving access to quality, affordable, and appropriately regulated essential medicines across the Republic of South Sudan.
Access to safe, effective, and quality-assured medicines is the fundamental cornerstone of every functional healthcare system. In the Republic of South Sudan, healthcare providers, clinics, and humanitarian responders often encounter severe supply chain volatility, protracted lead times, and the pervasive hazard of substandard and falsified (SF) products.
Eagles Pharma is conceived to bridge this critical gap. By establishing responsible, direct relationships with verified international pharmaceutical manufacturers and adhering strictly to international Good Distribution Practices (GDP), we intend to construct an uncompromised pharmaceutical corridor into South Sudan.
To become South Sudan's most trusted and compliant pharmaceutical distribution partner, transforming national healthcare access through unyielding quality standards.
To improve the availability, affordability, and integrity of life-saving medicines across hospitals, clinics, pharmacies, and humanitarian missions in South Sudan.
Targeted therapeutic categories selected to address the most urgent disease burdens and epidemiological priorities in South Sudan.
High Priority
Malaria represents the foremost cause of morbidity and pediatric mortality in South Sudan. Our planned portfolio focuses on WHO-recommended Artemisinin-based Combination Therapies (ACTs) and injectable solutions for severe complications.
Essential
Essential broad-spectrum antibacterial formulations for respiratory, gastrointestinal, and systemic bacterial infections, structured to support strict antimicrobial stewardship.
Core Care
Crucial pain management, fever reduction, and non-steroidal anti-inflammatory agents indispensable for outpatient clinics, surgical wards, and maternal healthcare facilities.
Chronic Care
Addressing South Sudan's growing double burden of disease with reliable maintenance therapies for cardiovascular hypertension, diabetes mellitus, and respiratory conditions.
Emergency & Maternal
Complementary healthcare supplies vital for trauma wards, humanitarian nutritional responses, and maternal/child health clinics across urban and rural settlements.
Are you an institutional healthcare leader, hospital director, or humanitarian logistics specialist? Partner with us in shaping therapeutic forecasting for South Sudan.
B2B & Institutional Supply Inquiries Only
To guarantee that medicines supplied to South Sudan comply with internationally recognized pharmaceutical manufacturing standards, Eagles Pharma is actively exploring a strategic distribution partnership with Addii Biotech Pvt. Ltd., India.
The ongoing discussions encompass the possibility of an exclusive distribution arrangement for the South Sudan market, securing a steady, audited pipeline of essential therapeutic formulations from certified production lines.
WHO-GMP & ISO Manufacturing Alignment
Our planned compliance architecture is built on the rigorous principles of WHO Good Distribution Practices (GDP) and the regulatory mandates of South Sudan's healthcare authorities.
A clear, phased roadmap guiding our transition from pre-incorporation preparation to official regulatory licensure and commercial healthcare distribution.
Establishing legal entity structure, governance policies, corporate branding, and partnership exploration frameworks.
Submitting formal documentation to the Drug and Food Control Authority of South Sudan for pharmaceutical wholesale distribution licensure.
Finalizing formal written contracts with manufacturer partners, product dossier clearances, and import permits.
Commissioning the central temperature-controlled warehouse in Juba and commencing institutional supplies to hospitals, clinics, and NGOs.
Whether you represent a pharmaceutical manufacturer exploring the South Sudan market, a healthcare institution seeking reliable future supplies, or a humanitarian NGO coordinating health logistics, we welcome early dialogue.
Legal disclosure regarding company status in the Republic of South Sudan
Pre-Incorporation & Licensing Status: Eagles Pharma is a proposed pharmaceutical distribution company currently in its formative and pre-launch preparation phase. It does not presently hold commercial marketing authorizations or pharmaceutical wholesale licences in South Sudan, which are currently being pursued in compliance with statutory procedures.
Eagles Pharma is not an online pharmacy, retail chemist, or medical advisory service. The company will not sell prescription medications directly to consumers or patients. The website contents are published purely for corporate and institutional informational purposes.
Mentions of prospective distribution collaborations, including dialogue with Addii Biotech Pvt. Ltd. (India) regarding potential exclusive distribution in South Sudan, are strictly exploratory. Any commercial relationship is contingent upon the execution of definitive written agreements, company registration, and formal product registration by national drug authorities.
All future operations, importation protocols, and distribution practices will strictly adhere to the guidelines established by the Ministry of Health and the Drug and Food Control Authority (DFCA) of the Republic of South Sudan.
Engage with the Eagles Pharma corporate development team
Thank you for reaching out to Eagles Pharma. Your prospective partnership inquiry has been registered in our development intake pipeline.